![]() |
|||||||||||||
|
All | Since 2019 | |
Citation | 5450 | 3969 |
h-index | 23 | 20 |
i10-index | 134 | 84 |
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF ELTROMBOPAG OLAMINE BY RP- HPLC METHOD
Ahesar Tamboli*, Prof. Shakeel Memon and Prof. Tabassum Hangad
ABSTRACT A reversed-phase liquid chromatographic method has been developed and validated for estimation of Eltrombopag Olamine in Pharmaceutical Dosage Form. RP-HPLC method, Column used was 150 x 4.6mm 5μ C18, Hypersil BDS with mobile phase containing 10mM Potassium dihydrogen Phosphate + 1% TEA (pH 4.5 Adjusted using Ortho phosphoric acid): Acetonitrile (50:50). The flow rate (1.0 ml/min) and wavelength (226 nm). The retention time of Eltrombopag Olamine was found to be 4.509 min, respectively. Correlation co-efficient for Eltrombopag Olamine was found to be 0.999. Assay result of marketed formulation was found to be in 99.7% for Eltrombopag Olamine. The proposed method was validated with respect to linearity, accuracy, precision and robustness. Percentage recovery for Eltrombopag Olamine was found to be 99.7 – 100.0%. Analysis proves that the developed method was successfully applied for the analysis of pharmaceutical formulations and can be used for routine analysis of drugs in Quality Control laboratories. Keywords: Analytical method development, validation, Eltrombopag Olamine, HPLC, ICH guidelines. [Download Article] [Download Certifiate] |